Barclays raised the firm’s price target on GSK to 1,575 GBp from 1,450 GBp and keeps an Equal Weight rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GSK:
- GSK participates in a conference call hosted by Jefferies
- GSK says FDA approves Ojjaara for treatment of myelofibrosis
- DiaMedica appoints Ambarish Shah, Ph.D. as Chief Technology Officer
- GSK momelotinib submission for myelofibrosis accepted for review by Japan’s MHLW
- Tonix Pharmaceuticals plans to meet potential increased demand for Tosymra